Chaired by the scientist and entrepreneur Stefano Buono, LIFTT came to life as an operating company in 2019 thanks to Compagnia di San Paolo, Politecnico di Torino and LINKS Foundation.
The aim is to encourage technology development and transfer from University to Industry, but also to clear the way from a simple business idea to the creation of an innovative product, offering a dynamic and modern vision of venture capital as applied to Technology Transfer.
LIFTT guarantees high visibility to ideas and new businesses at a national and international level, investing and attracting capital and ensuring maximum impact on the local and national territory. While generating value for its shareholders, LIFTT supports the creation of businesses, development, employment and economic growth, through the implementation of an ethical and transparent governance model, based on the participation of all the actors involved.
The aim is to encourage technology development and transfer from University to Industry, but also to clear the way from a simple business idea to the creation of an innovative product, offering a dynamic and modern vision of venture capital as applied to Technology Transfer.
LIFTT guarantees high visibility to ideas and new businesses at a national and international level, investing and attracting capital and ensuring maximum impact on the local and national territory. While generating value for its shareholders, LIFTT supports the creation of businesses, development, employment and economic growth, through the implementation of an ethical and transparent governance model, based on the participation of all the actors involved.
Location: Italy, Piedmont, Turin
Employees: 11-50
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Elysia Cap... | elysiacapi... |
Mentions in press and media 10
| Date | Title | Description |
| 13.09.2024 | $62M for biogas power plants, Atomico's new $1.24B funding, and Europe's competitive decline | This week we tracked more than 95 tech funding deals worth over €1 billion, and over 10 exits, M&A transactions, rumours, and related news stories across Europe. In addition to this week's top financials, we've also indexed the most imp... |
| 18.04.2024 | Evergreen Theragnostics Secures $26M to Drive Radiopharmaceutical Innovation | Evergreen Theragnostics, a cutting-edge radiopharmaceutical company based in Springfield, NJ, has successfully completed a $26M capital raise, with support from Petrichor and LIFTT. This funding will propel the company's groundbreaking rese... |
| 16.04.2024 | Evergreen Theragnostics Completes $26M Capital Raise to Advance Novel Radiopharmaceutical Pipeline into the Clinic, Prepare for First Commercial Product Launch, and Expand Industry-Leading CDMO Servic... | SPRINGFIELD, N.J., April 16, 2024 /PRNewswire/ -- Evergreen Theragnostics, Inc., a clinical-stage radiopharmaceutical company, today announced the successful completion of a $26M capital raise supported both by existing shareholders and new... |
| 17.08.2023 | Comptek Solutions secures €8M Series A funding for semiconductor tech expansion | Finnish semiconductor firm Comptek Solutions has raised €8 million in a Series A funding round which includes participation from the EIC Fund and LIFTT S.p.A. The company is a spin-out of University of Turku, it was founded in June 2017 by ... |
| 17.08.2023 | Finland’s Comptek Solutions secures €8M in Series A funding | Finland’s Comptek Solutions secures €8M in Series A funding 17 August, 2023, 17:21 Rostyslav Sobachynskyi --> --> --> -->--> --> --> --> --> --> --> --> --> Tukru-based Comptek Solutions has secured... |
| 28.06.2023 | EUR 14.35 million to advance cardiac radiation ablation therapy | |
| 11.05.2023 | Denmarks Sparrow Quantum raises €4.1 million for its integrated chip for on-demand single-photon streams | Danish quantum technology company Sparrow Quantum has raised €4.1 million in seed funding. The funding round was led by the venture capital firm 2xN and includes co-investment from LIFTT and the European Innovation Council (EIC). The invest... |
| 20.06.2022 | With a new approach to nuclear, London’s newcleo clears €300 million in equity raise | London-based newcleo has raised €300 million in an equity funding round. The company is taking a new approach to nuclear energy extraction, one that it claims is ‘completely safe, clean, renewable and technologically accessible’ through its... |
| - | An international pool invests ~ 2 Mio € in mediaire, the preventive medicine start-up “Made in Germany” | HTGF, primeCROWD and LIFTT are part of an international round for the development of “Deep learning diagnostic” which allows faster, more accurate and safer MRI analysis. Expansion into European markets will start in 2021 accompanied by a s... |
| - | With a new approach to nuclear, London’s newcleo clears €300 million in equity raise | London-based newcleo has raised €300 million in an equity funding round. The company is taking a new approach to nuclear energy extraction, one that it claims is ‘completely safe, clean, renewable and technologically accessible’ through its... |